Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 16 April 2024, 17:04 HKT/SGT
Share:
    

Source: Autonomix Medical Inc.
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology

NEW YORK, Apr 16, 2024 - (ACN Newswire) - A new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders, has been published by Benzinga. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology.

The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related disorders. By targeting the root causes associated with the PNS, rather than just managing symptoms, Autonomix Medical's technology offers a novel solution that combines both detection and ablation of problematic nerves in a single procedure. This approach, likened to a "GPS" for nerve treatment, allows for precise identification and treatment of the nerves involved, enhancing the accuracy and effectiveness of procedures.

In a notable application, the company is focusing its efforts on managing pancreatic cancer pain — a condition notoriously difficult to treat due to its proximity to critical nerves. The technology's high sensitivity in detecting neural signals—up to 3,000 times greater than existing technologies — promises not only to improve outcomes in pain management but also to significantly reduce the need for opioids, addressing a major public health challenge.

This exposure in Benzinga underscores the potential of Autonomix Medical's technology to transform the field of electrophysiology and pain management, potentially tapping into a market exceeding $100 billion. As the company progresses with its clinical trials, the successful implementation of its technology could revolutionize treatment approaches for a wide range of diseases, offering hope to millions of patients worldwide.

To read the full article, click here.

More Pancreatic Cancer News:

  • Candel Therapeutics, Inc. ((Nasdaq: CADL) announced that the FDA has granted Orphan Drug Designation to their advanced biological immunotherapy, CAN-2409, for treating pancreatic cancer, following promising phase 2 clinical trial results that more than doubled median overall survival when added to standard care.
  • RenovoRx, Inc. (Nasdaq: RNXT) announced an $11.1 million private placement, extending their financial runway into 2026, which will support the continuation and completion of their pivotal Phase III TIGeR-PaC clinical trial for pancreatic cancer. This funding also facilitates the expansion of their Trans-Arterial Micro-Perfusion (TAMP) clinical development pipeline into additional cancer indications.

Note: The details provided in this press release are based on information featured in the Benzinga article and do not constitute forward-looking statements.

For more information, contact:
Plato Data Intelligence
144 E44th St
New York NY 10017
PlatoAiStream.com
Zephyr@platodata.io

 




Topic: Press release summary
Source: Autonomix Medical Inc.

Sectors: Healthcare & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Vietnam: International Dairy Product launches nutritious KUN milk with jelly pieces in SIG XSlimBloc carton packs  
May 20, 2024 19:30 HKT/SGT
InsureTech Connect Asia: Asia's Largest Insurance Ecosystem Conference  
May 20, 2024 18:08 HKT/SGT
BEAST (Bengkel Animasi Digital Arts & Creative Festival) 2024 goes back to Bandung  
May 20, 2024 18:00 HKT/SGT
Paw Pro GmbH Announces $1.5M Partnership with Health Reasoning to Launch Innovative Web3 Platform  
May 20, 2024 17:03 HKT/SGT
Response to Africa Intelligence Article  
May 20, 2024 17:00 HKT/SGT
Shaping a Green Future for Textile Industry- Aimer 2024 New Presentation of Seaweed Fiber Pajamas  
May 20, 2024 17:00 HKT/SGT
Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market  
May 20, 2024 16:00 HKT/SGT
The cybersecurity capital of Philippines, PhilSec now an essential choice for critical infrastructure   
May 20, 2024 15:43 HKT/SGT
MHI Receives Order for Additional 12 Units of the Outer Vertical Target for the Divertor Used in the ITER in Southern France  
Monday, May 20, 2024 10:36:00 AM
REDEX to be an exclusive partner to TNBX in Malaysia to support the Malaysia Green Attribute Trading System (mGATS) platform  
May 20, 2024 10:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: